Raab, M.; Gasimli, K.; Győrffy, B.; Peña-Llopis, S.; Becker, S.; Sanhaji, M.; Strebhardt, K.
Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer. Cancers 2025, 17, 1910.
https://doi.org/10.3390/cancers17121910
AMA Style
Raab M, Gasimli K, Győrffy B, Peña-Llopis S, Becker S, Sanhaji M, Strebhardt K.
Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer. Cancers. 2025; 17(12):1910.
https://doi.org/10.3390/cancers17121910
Chicago/Turabian Style
Raab, Monika, Khayal Gasimli, Balázs Győrffy, Samuel Peña-Llopis, Sven Becker, Mourad Sanhaji, and Klaus Strebhardt.
2025. "Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer" Cancers 17, no. 12: 1910.
https://doi.org/10.3390/cancers17121910
APA Style
Raab, M., Gasimli, K., Győrffy, B., Peña-Llopis, S., Becker, S., Sanhaji, M., & Strebhardt, K.
(2025). Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer. Cancers, 17(12), 1910.
https://doi.org/10.3390/cancers17121910